alternatively, there may be mutations in the DNA, leading to the development of diseases [2,3,4,16]
Anecdotal reports from users have included: Commonly Reported: Injection site pain, redness, or swelling Mild dizziness Nausea Fatigue or drowsiness Less Commonly Reported: Anxiety or mood changes Heart palpitations Insomnia Loss of appetite Depression or anhedonia The FDA has noted that BPC-157 may pose an immunogenicity risk (triggering an immune response)
For these reasons, and because of the complex nature of mitochondrial genetics, it has been proposed that many people with common neuropsychiatric disorders, including autism, have dysregulation of mitochondrial energy metabolism (59)
While mild to moderate fatigue is common with GLP-1s, it should not be debilitating
When pharmacists are a part of the care process, outcomes improve
No therapeutic or diagnostic use is implied or authorized